Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack-Reference-Cited by-同舟云学术

Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack

Published:2022-01-10 Issue: Volume: Page:
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Annals of Neurology

Author:

Wang Anxin¹²^ORCID,Meng Xia¹²,Tian Xue¹²³⁴,Johnston S. Claiborne⁵,Li Hao¹²,Bath Philip M.⁶,Zuo Yingting¹²³⁴,Xie Xuewei¹²^ORCID,Jing Jing¹²^ORCID,Lin Jinxi¹²,Wang Yilong¹²,Zhao Xingquan¹²^ORCID,Li Zixiao¹²,Jiang Yong¹²,Liu Liping¹²,Wang Feng⁷,Li Ying⁸,Liu Jingyao⁹,Wang Yongjun¹²¹⁰,

Affiliation:

1. Department of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China

2. China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital Capital Medical University Beijing China

3. Department of Epidemiology and Health Statistics, School of Public Health Capital Medical University Beijing China

4. Beijing Municipal Key Laboratory of Clinical Epidemiology Beijing China

5. Dell Medical School University of Texas at Austin Austin TX USA

6. Stroke Trials Unit, Mental Health and Clinical Neuroscience University of Nottingham Nottingham UK

7. Department of Neurology Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine Shanghai China

8. Department of Neurology Suixian Chinese Medicine Hospital Henan China

9. Department of Neurology First Hospital of Jilin University Jilin China

10. Advanced Innovation Center for Human Brain Protection, Beijing Tiantan Hospital Capital Medical University Beijing China

Funder

National Science and Technology Major Project

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.26287

Reference32 articles.

1. Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack

2. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA

3. Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA;Kaushik A;N Engl J Med,2020

4. Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies

5. Ticagrelor versus clopidogrel in CYP2C19 loss‐of‐function carriers with stroke or TIA;Wang Y;N Engl J Med,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of CYP2C19 Genotype Status on Clinical Outcomes in Patients with Symptomatic Coronary Artery Disease, Stroke, and Peripheral Arterial Disease: A Systematic Review and Meta-Analysis;Drugs;2024-09-05

2. LDL-C Levels and Bleeding Risk in Patients Taking DAPT After Minor Ischemic Stroke or TIA;JAMA Neurology;2024-04-01

3. Effects of remnant cholesterol on the efficacy of genotype-guided dual antiplatelet in CYP2C19 loss-of -function carriers with minor stroke or transient ischaemic attack: a post-hoc analysis of the CHANCE-2 trial;eClinicalMedicine;2024-01

4. Effect of Platelet Function Testing Guidance on Clinical Outcomes for Patients with Intracranial Aneurysms Undergoing Endovascular Treatment;American Journal of Neuroradiology;2023-07-06

5. Recommending Drug Combinations using Reinforcement Learning to target Genes/proteins that cause Stroke: A comprehensive Systematic Review and Network Meta-analysis;2023-04-22